Folgen
Catherine Coveney
Catherine Coveney
Bestätigte E-Mail-Adresse bei lboro.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Callers’ experiences of contacting a national suicide prevention helpline
CM Coveney, K Pollock, S Armstrong, J Moore
Crisis, 2012
1102012
The sociology of cognitive enhancement: Medicalisation and beyond
C Coveney, J Gabe, S Williams
Health Sociology Review 20 (4), 381-393, 2011
1082011
Modafinil in the media: metaphors, medicalisation and the body
CM Coveney, B Nerlich, P Martin
Social Science & Medicine 68 (3), 487-495, 2009
842009
Managing sleep and wakefulness in a 24‐hour world
CM Coveney
Sociology of health & illness 36 (1), 123-136, 2014
712014
Medicalisation or customisation? Sleep, enterprise and enhancement in the 24/7 society
SJ Williams, CM Coveney, J Gabe
Social science & medicine 79, 40-47, 2013
662013
‘M‐apping’sleep? Trends and transformations in the digital age
SJ Williams, C Coveney, R Meadows
Sociology of Health & Illness 37 (7), 1039-1054, 2015
632015
Pharmaceuticals and society: power, promises and prospects
J Gabe, S Williams, P Martin, C Coveney
Social Science & Medicine 131, 193-198, 2015
582015
Commercial development of stem cell technology: lessons from the past, strategies for the future
PA Martin, C Coveney, A Kraft, N Brown, P Bath
Future Medicine Ltd 1 (6), 801-807, 2006
562006
Cognitive enhancement? Exploring modafinil use in social context
CM Coveney
Sociological reflections on the neurosciences 13, 203-228, 2011
522011
Prescriptions and proscriptions: moralising sleep medicines
J Gabe, CM Coveney, SJ Williams
Sociology of health & illness 38 (4), 627-644, 2016
512016
An evaluation of Samaritans telephone and email emotional support service
K Pollock, S Armstrong, C Coveney, J Moore
University of Nottingham, 2010
342010
The concept of medicalisation reassessed: a response to Busfield
SJ Williams, C Coveney, J Gabe
Sociology of Health & Illness 39 (5), 775-780, 2017
322017
Enhancement imaginaries: exploring public understandings of pharmaceutical cognitive enhancing drugs
C Coveney, SJ Williams, J Gabe
Drugs: Education, Prevention and Policy 26 (4), 319-328, 2019
262019
Medicalisation, pharmaceuticalisation, or both? Exploring the medical management of sleeplessness as insomnia
C Coveney, SJ Williams, J Gabe
Sociology of health & illness 41 (2), 266-284, 2019
262019
Where biomedicalisation and magic meet: Therapeutic innovations of elite sports injury in British professional football and cycling
A Faulkner, M McNamee, C Coveney, J Gabe
Social Science & Medicine 178, 136-143, 2017
242017
Configuring the caller in ambiguous encounters: Volunteer handling of calls to Samaritans emotional support services
K Pollock, J MOOrE, C Coveney, S ArMStrONg
Communication & Medicine 9 (2), 113-123, 2012
222012
Pharmaceutical cognitive enhancement: Interrogating the ethics, addressing the issues
PA Martin, M Pickersgill, C Coveney, S Williams
Augmenting cognition, 179-192, 2011
212011
Making sense of pharmaceutical cognitive enhancement: Taking stock and looking forward
C Coveney, J Bjønness
Drugs: Education, Prevention and Policy 26 (4), 293-300, 2019
202019
Desynchronised times? Chronobiology,(bio) medicalisation and the rhythms of life itself
SJ Williams, R Meadows, CM Coveney
Sociology of Health & Illness 43 (6), 1501-1517, 2021
192021
Reframing egg donation in Europe: new regulatory challenges for a shifting landscape
N Hudson, L Culley, C Herbrand, V Pavone, G Pennings, V Provoost, ...
Health Policy and Technology 9 (3), 308-313, 2020
162020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20